OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00274159

Guangdong Guanghua Sci-Tech Co Ltd

Commodity ChemicalsVerified

Guangdong Guanghua Sci-Tech Co Ltd has a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure. The company's liquidity is assessed as medium, with a current ratio of 1.38, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not in excess. Free cash flow for the period was 99,072,170 CNY, which is a positive sign of operational efficiency and financial flexibility. The company's profitability is modest, with a return on equity of 5.37% and a return on assets of 2.76%. These figures are below the typical thresholds for high-performing chemical companies, indicating that the company is not generating strong returns relative to its equity and asset base. The operating margin, calculated as operating income divided by revenue, is 3.92%, which is in line with the industry's median for commodity chemicals. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. The company's business is primarily driven by its domestic market, which exposes it to local economic conditions and regulatory changes. The company does not report revenue by business segment, making it difficult to assess the contribution of different product lines to overall performance. The company's growth trajectory is mixed. Revenue for the period was 2.96 billion CNY, and while the company has a positive free cash flow, there is no indication of significant revenue growth in the near term. The company's capital expenditure was negative at -91,970,390 CNY, suggesting that it is not investing heavily in new projects or expansion. Analysts have a neutral outlook, with one "buy" recommendation and no "strong buy" or "sell" recommendations. The company faces several risk factors, including medium liquidity risk and the potential for dilution, although the risk of dilution is assessed as low. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing. The company has not issued any recent equity, and there are no indications of imminent dilution from new share offerings or convertible instruments. Recent events and disclosures indicate that the company has not filed any significant new reports or issued notable press releases. The company's financial performance and strategic direction appear to be stable, with no major changes in its business model or operational strategy. The company's recent earnings per share (EPS) of 0.22 CNY were below the mean analyst estimate of 0.34 CNY, suggesting that the company may be underperforming relative to expectations.

30-day price · 002741(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyGuangdong Guanghua Sci-Tech Co Ltd
Ticker002741.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Guangdong Guanghua Sci-Tech Co Ltd is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Guangdong Guanghua Sci-Tech Co Ltd has a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure. The company's liquidity is assessed as medium, with a current ratio of 1.38, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not in excess. Free cash flow for the period was 99,072,170 CNY, which is a positive sign of operational efficiency and financial flexibility. The company's profitability is modest, with a return on equity of 5.37% and a return on assets of 2.76%. These figures are below the typical thresholds for high-performing chemical companies, indicating that the company is not generating strong returns relative to its equity and asset base. The operating margin, calculated as operating income divided by revenue, is 3.92%, which is in line with the industry's median for commodity chemicals. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. The company's business is primarily driven by its domestic market, which exposes it to local economic conditions and regulatory changes. The company does not report revenue by business segment, making it difficult to assess the contribution of different product lines to overall performance. The company's growth trajectory is mixed. Revenue for the period was 2.96 billion CNY, and while the company has a positive free cash flow, there is no indication of significant revenue growth in the near term. The company's capital expenditure was negative at -91,970,390 CNY, suggesting that it is not investing heavily in new projects or expansion. Analysts have a neutral outlook, with one "buy" recommendation and no "strong buy" or "sell" recommendations. The company faces several risk factors, including medium liquidity risk and the potential for dilution, although the risk of dilution is assessed as low. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing. The company has not issued any recent equity, and there are no indications of imminent dilution from new share offerings or convertible instruments. Recent events and disclosures indicate that the company has not filed any significant new reports or issued notable press releases. The company's financial performance and strategic direction appear to be stable, with no major changes in its business model or operational strategy. The company's recent earnings per share (EPS) of 0.22 CNY were below the mean analyst estimate of 0.34 CNY, suggesting that the company may be underperforming relative to expectations.
Key takeaways
  • Guangdong Guanghua Sci-Tech Co Ltd has a balanced capital structure with a debt-to-equity ratio of 0.5.
  • The company's profitability is modest, with a return on equity of 5.37% and a return on assets of 2.76%.
  • The company's revenue is concentrated in China, with no disclosed international operations.
  • The company's growth trajectory is mixed, with no significant revenue growth in the near term.
  • The company faces medium liquidity risk and the potential for dilution, although the risk of dilution is assessed as low.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.96B
Gross profit$453.4M
Operating income$116.1M
Net income$103.9M
R&D
SG&A
D&A
SBC
Operating cash flow$18.8M
CapEx-$92.0M
Free cash flow$99.1M
Total assets$3.77B
Total liabilities$1.83B
Total equity$1.94B
Cash & equivalents
Long-term debt$959.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.94B
Net cash-$959.3M
Current ratio1.4
Debt/Equity0.5
ROA2.8%
ROE5.4%
Cash conversion18.0%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002741Activity
Op margin3.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.5%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin15.3%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity50.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.34 CNY
Last actual EPS0.22 CNY
Mean revenue estimate3,512,000,000 CNY
Last actual revenue2,964,315,810 CNY
Mean EBIT estimate228,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 03:37 UTCJob: a2549113